Astec LifeSciences Future Growth
Future criteria checks 5/6
Astec LifeSciences is forecast to grow earnings and revenue by 112.2% and 34.3% per annum respectively while EPS is expected to grow by 112.2% per annum.
Key information
112.2%
Earnings growth rate
112.2%
EPS growth rate
Chemicals earnings growth | 20.2% |
Revenue growth rate | 34.3% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 09 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2026 | 8,716 | 931 | N/A | N/A | 1 |
3/31/2025 | 6,756 | 579 | N/A | N/A | 1 |
3/31/2024 | 4,300 | -425 | N/A | N/A | 1 |
12/31/2023 | 4,317 | -509 | N/A | N/A | N/A |
9/30/2023 | 4,981 | -258 | -1,580 | 101 | N/A |
6/30/2023 | 5,871 | 60 | N/A | N/A | N/A |
3/31/2023 | 6,285 | 256 | -426 | 747 | N/A |
12/31/2022 | 7,735 | 736 | N/A | N/A | N/A |
9/30/2022 | 8,297 | 975 | -448 | 351 | N/A |
6/30/2022 | 7,325 | 883 | N/A | N/A | N/A |
3/31/2022 | 6,769 | 899 | -804 | 236 | N/A |
12/31/2021 | 5,803 | 708 | N/A | N/A | N/A |
9/30/2021 | 5,230 | 531 | -800 | 483 | N/A |
6/30/2021 | 5,754 | 619 | N/A | N/A | N/A |
3/31/2021 | 5,587 | 650 | -1,107 | -82 | N/A |
12/31/2020 | 5,698 | 723 | N/A | N/A | N/A |
9/30/2020 | 5,786 | 774 | 1,190 | 1,885 | N/A |
6/30/2020 | 5,639 | 648 | N/A | N/A | N/A |
3/31/2020 | 5,287 | 475 | 1,231 | 1,684 | N/A |
12/31/2019 | 4,844 | 291 | N/A | N/A | N/A |
9/30/2019 | 4,781 | 269 | -420 | 32 | N/A |
6/30/2019 | 4,507 | 331 | N/A | N/A | N/A |
3/31/2019 | 4,382 | 357 | -375 | 153 | N/A |
12/31/2018 | 4,246 | 402 | N/A | N/A | N/A |
9/30/2018 | 3,781 | 374 | N/A | N/A | N/A |
6/30/2018 | 3,611 | 325 | N/A | N/A | N/A |
3/31/2018 | 3,676 | 349 | 150 | 647 | N/A |
12/31/2017 | 3,254 | 212 | N/A | N/A | N/A |
9/30/2017 | 3,119 | 148 | N/A | N/A | N/A |
6/30/2017 | 3,008 | 192 | N/A | N/A | N/A |
3/31/2017 | 2,987 | 191 | N/A | 192 | N/A |
12/31/2016 | 3,167 | -29 | N/A | N/A | N/A |
9/30/2016 | 2,865 | -114 | N/A | N/A | N/A |
6/30/2016 | 2,643 | -206 | N/A | N/A | N/A |
3/31/2016 | 2,330 | 50 | N/A | -125 | N/A |
12/31/2015 | 2,629 | -115 | N/A | N/A | N/A |
9/30/2015 | 2,777 | 61 | N/A | N/A | N/A |
6/30/2015 | 2,728 | 84 | N/A | N/A | N/A |
3/31/2015 | 2,669 | 148 | N/A | 75 | N/A |
12/31/2014 | 2,212 | 131 | N/A | N/A | N/A |
9/30/2014 | 2,147 | 127 | N/A | N/A | N/A |
6/30/2014 | 2,156 | 96 | N/A | N/A | N/A |
3/31/2014 | 2,070 | 87 | N/A | 146 | N/A |
12/31/2013 | 2,179 | 97 | N/A | N/A | N/A |
9/30/2013 | 2,076 | 76 | N/A | N/A | N/A |
6/30/2013 | 1,849 | 72 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 533138 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (6.7%).
Earnings vs Market: 533138 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 533138 is expected to become profitable in the next 3 years.
Revenue vs Market: 533138's revenue (34.3% per year) is forecast to grow faster than the Indian market (10% per year).
High Growth Revenue: 533138's revenue (34.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 533138's Return on Equity is forecast to be high in 3 years time